BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26777411)

  • 1. Recurrent copy number variations as risk factors for autism spectrum disorders: analysis of the clinical implications.
    Oikonomakis V; Kosma K; Mitrakos A; Sofocleous C; Pervanidou P; Syrmou A; Pampanos A; Psoni S; Fryssira H; Kanavakis E; Kitsiou-Tzeli S; Tzetis M
    Clin Genet; 2016 Jun; 89(6):708-18. PubMed ID: 26777411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
    Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.
    Hnoonual A; Thammachote W; Tim-Aroon T; Rojnueangnit K; Hansakunachai T; Sombuntham T; Roongpraiwan R; Worachotekamjorn J; Chuthapisith J; Fucharoen S; Wattanasirichaigoon D; Ruangdaraganon N; Limprasert P; Jinawath N
    Sci Rep; 2017 Sep; 7(1):12096. PubMed ID: 28935972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services.
    Roberts JL; Hovanes K; Dasouki M; Manzardo AM; Butler MG
    Gene; 2014 Feb; 535(1):70-8. PubMed ID: 24188901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
    Shin S; Yu N; Choi JR; Jeong S; Lee KA
    Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights in the interpretation of array-CGH: autism spectrum disorder and positive family history for intellectual disability predict the detection of pathogenic variants.
    Cappuccio G; Vitiello F; Casertano A; Fontana P; Genesio R; Bruzzese D; Ginocchio VM; Mormile A; Nitsch L; Andria G; Melis D
    Ital J Pediatr; 2016 Apr; 42():39. PubMed ID: 27072107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
    Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
    Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
    Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
    Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution chromosomal microarray analysis for copy-number variations in high-functioning autism reveals large aberration typical for intellectual disability.
    Werling AM; Grünblatt E; Oneda B; Bobrowski E; Gundelfinger R; Taurines R; Romanos M; Rauch A; Walitza S
    J Neural Transm (Vienna); 2020 Jan; 127(1):81-94. PubMed ID: 31838600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic efficacy and new variants in isolated and complex autism spectrum disorder using molecular karyotyping.
    Lovrečić L; Rajar P; Volk M; Bertok S; Gnidovec Stražišar B; Osredkar D; Jekovec Vrhovšek M; Peterlin B
    J Appl Genet; 2018 May; 59(2):179-185. PubMed ID: 29564645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
    Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
    J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.
    Sharma P; Gupta N; Chowdhury MR; Sapra S; Ghosh M; Gulati S; Kabra M
    Gene; 2016 Sep; 590(1):109-19. PubMed ID: 27291820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
    Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
    Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic yield of the chromosomal microarray analysis in turkish patients with unexplained development delay/ıntellectual disability(ID), autism spectrum disorders and/or multiple congenital anomalies and new clinical findings.
    Akkus N; Cubuk PO
    Mol Biol Rep; 2024 Apr; 51(1):577. PubMed ID: 38664339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.
    Lee JS; Hwang H; Kim SY; Kim KJ; Choi JS; Woo MJ; Choi YM; Jun JK; Lim BC; Chae JH
    Ann Lab Med; 2018 Sep; 38(5):473-480. PubMed ID: 29797819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular characterization of three genomic rearrangements at chromosome 22q13.3 associated with autism spectrum disorder.
    Chen CH; Chen HI; Liao HM; Chen YJ; Fang JS; Lee KF; Gau SS
    Psychiatr Genet; 2017 Feb; 27(1):23-33. PubMed ID: 27846046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare copy number variants are common in young children with autism spectrum disorder.
    Eriksson MA; Liedén A; Westerlund J; Bremer A; Wincent J; Sahlin E; Gillberg C; Fernell E; Anderlid BM
    Acta Paediatr; 2015 Jun; 104(6):610-8. PubMed ID: 25661985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of rare copy number variations reveals PJA2, APCS, SYNPO, and TAC1 as novel candidate genes in Autism Spectrum Disorders.
    Bitar T; Hleihel W; Marouillat S; Vonwill S; Vuillaume ML; Soufia M; Vourc'h P; Laumonnier F; Andres CR
    Mol Genet Genomic Med; 2019 Aug; 7(8):e786. PubMed ID: 31254375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution SNP genotyping platform identified recurrent and novel CNVs in autism multiplex families.
    AlAyadhi LY; Hashmi JA; Iqbal M; Albalawi AM; Samman MI; Elamin NE; Bashir S; Basit S
    Neuroscience; 2016 Dec; 339():561-570. PubMed ID: 27771533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.